Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials

Gentile M;Specchia G;Derudas D;Galli M;Botta C;Rocco S;Conticello C;Califano C;Giuliani N;Mangiacavalli S;Attingenti E;Lombardo A;Brunori M;Rossi E;Antonioli E;Ria R;Zambello R;Di Renzo N;Mele G;Marcacci G;Musto P;Capalbo S;Cascavilla N;Cerchione C;Belotti A;Criscuolo C;Uccello G;Curci P;Vigna E;Fraticelli V;Vincelli D;Bonalumi A;Siniscalchi A;Stocchi R;Martino M;Ballanti S;Gangemi D;Gagliardi A;Gamberi B;Pompa A;Recchia AG;Tripepi G;Pitino A;Frigeri F;Consoli U;Bringhen S;Zamagni E;Patriarca F;De Stefano V;Di Raimondo F;Palmieri S;Petrucci MT;Offidani M;Boccadoro M;Cavo M;Morabito F.

2020-01-01